|
⚲
|
| MBF Therapeutics Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001458729 |
| Sale | 2009-03-05 ($1.0 M Offered, $0.3 M Sold) |
| Fund | |
| Phone | 2156203699 |
| Address | 640 Woodbrook Drive Ambler, 19002 |
| Source | [EDGAR] |
| Fund AUM and Sold ($k) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Christopher Cashman | |
| Thomas Tillett | |
| Christopher Ragland |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
ExchangeRight Net-Leased Portfolio 63 DST
✚
|
0.0 | |
|
ExchangeRight Value-Add Portfolio 3 DST
✚
|
0.0 | |
|
IIFL Opportunities Fund 10
✚
|
0.0 | |
|
IIFL Opportunities Fund 3
✚
|
0.0 | |
|
Executive Council Network, Inc.
✚
|
0.0 | |
|
Executive Enterprise Venture Fund, LP - B2
✚
|
0.0 | |
|
BIAS Jonathan Mark
✚
|
0.0 | |
|
BIF - Northside Coinvest, LLC
✚
|
0.0 | |
|
BI Fund II, a series of Naval Ravikant AngelList Funds, LP
✚
|
0.0 | |
|
Bastion Fiduciary LLC
✚
|
0.0 |